Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Comparison of Enteral Versus Parenteral Feeding in Healthy Human Subjects (Feeding)

This study has been completed.
Information provided by (Responsible Party):
Rutgers, The State University of New Jersey Identifier:
First received: March 4, 2009
Last updated: May 20, 2015
Last verified: May 2015
Literature suggests that route of feeding and/or certain nutrients may cause alterations in the body's immune cells. Immune cells help protect the body and fight infection/disease. Tube feeding (TF) is a method of delivering nutrition directly to the stomach/intestines via a small tube. The immune system may respond differently when receiving continuous TF as compared to receiving intermittent TF. Heart rate variability (HRV, the intervals between heartbeats) is a measurement of the nervous system's response to a stress/illness. The differences in immune cells and/or HRV may influence how the body reacts to complications such as infection.

Condition Intervention Phase
Dietary Supplement: Enteral Continuous
Dietary Supplement: Enteral Intermittent
Dietary Supplement: Parenteral Continuous
Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Basic Science
Official Title: Comparison of Enteral Versus Parenteral Feeding in Healthy Human Subjects

Further study details as provided by Rutgers, The State University of New Jersey:

Primary Outcome Measures:
  • Route and type of feeding on Immune response [ Time Frame: Day 1- Day 4 ]

Enrollment: 12
Study Start Date: February 2009
Study Completion Date: March 2011
Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Enteral Continuous
Continuous tube feeding for 72 hours.
Dietary Supplement: Enteral Continuous
Continuous Tube Feeding for 72 hours
Active Comparator: Enteral Intermittent
Intermittent tube feedings for 72 hours
Dietary Supplement: Enteral Intermittent
Intermittent Tube Feedings
Active Comparator: Parenteral
Parenteral continuously for 72 hours
Dietary Supplement: Parenteral Continuous
Parenteral Continuously for 72 hours


Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • General good health as demonstrated by medical history, physical& laboratory tests
  • Age between 18 and 40 years
  • Written informed consent prior to the performance of any study related procedures

Exclusion Criteria:

  • History of cancer, rheumatoid arthritis, or immunological, renal, hepatic, endocrine, neurologic, heart disease or hypertension
  • Any medication taken in past 48 hrs (except birth control)
  • Recent history of alcohol or drug abuse
  • Unable to provide written informed consent
  • Exposure to any experimental agent or procedure within 30 days of study
  • Pregnant or breast-feeding
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00856219

United States, New Jersey
New Brunswick, New Jersey, United States, 08901
Sponsors and Collaborators
Rutgers, The State University of New Jersey
Principal Investigator: Siobhan Corbett, MD Rutgers-RWJMS
  More Information

Responsible Party: Rutgers, The State University of New Jersey Identifier: NCT00856219     History of Changes
Other Study ID Numbers: 0220044983
Study First Received: March 4, 2009
Last Updated: May 20, 2015

Keywords provided by Rutgers, The State University of New Jersey:
Immune System processed this record on May 25, 2017